Latest news

Communication is a fundamental human right. Associate Professor Anne Whitworth from Curtin University is developing a new NARNIA Communication App to help people with communication issues after stroke. This is one of the newly funded projects from our record-breaking $10 million research contribution in 2021.

It is with sadness we advise that Dr Greg Brotherson passed away on Friday, 6 August 2021.

Over her 25 years as a volunteer, employee and Client, Caroline Clarke-Smith has seen MSWA’s presence in Albany grow from a small support group to the development of a $7m facility for people living with neurological conditions.

Aubagio (teriflunomide) a medication used to treat multiple sclerosis is being delisted in Australia by Sanfoli. Generic medications remain available.

Today, MSWA is proud to announce that in this 2021/22 financial year, we are committing a record-breaking amount of $10 million to neurological research.

A study funded by MSWA is examining factors influencing quality of life for people living with motor neurone disease (MND).

A new national study identified the need for greater emotional support at end of life for family carers of people with motor neurone disease (MND).

MSWA CEO will step down from his role in October after 19 years at the helm.

Today, on International Nurses Day we celebrate the impact our nurses have on the healthcare system and neurological care.

Ofatumumab (Kesimpta®) to be subsidised under the Pharmaceutical Benefit Scheme (PBS).